CPA5 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8WXQ8 |
---|---|
Clone Names | 80410130 |
Gene ID | 93979 |
---|---|
Other Names | Carboxypeptidase A5, 3417-, CPA5 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP7349b was selected from the C-term region of human CPA5. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CPA5 |
---|---|
Cellular Location | Secreted. |
Tissue Location | Expression is very low or not detectable. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
CPA5 has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. This protein contains an approximately 90-amino acid pro region that assists in the folding of the active carboxypeptidase domain.
References
Bentley,L., Nakabayashi,K. J. Med. Genet. 40 (4), 249-256 (2003)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.